The ETH Zurich together with IBM Research share and operate one of Europe’s most advanced nanotechnology research centers. The Binning and Rohrer Nanotechnology Center in Rueschlikon (BRNC) is housing all necessary systems for design, manufacturing and testing of silicon nanowire sensing technology and is fully accessible to AD for development purposes. The close proximity to the University Hospital Zurich and other medical facilities enables us to support our customers in clinical validation of diagnostic tests according to US and EU regulatory approval processes (ISO:13485, FDA, Regulation (EU) 2017/746 on in-vitro diagnostic medical devices)